Actionnariat et activité des initiés pour PMV Pharmaceuticals, Inc. (PMVP): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.43 |
| Capitalisation | $76M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-04 | Stelzer Laurie | A-Award | 42,000 | $50K |
| 2026-06-04 | LEVINE ARNOLD J | A-Award | 42,000 | $50K |
| 2026-06-04 | Gallagher Carol Giltner | A-Award | 42,000 | $50K |
| 2026-06-04 | Gallagher Carol Giltner | G-Gift | 42,000 | $50K |
| 2026-06-04 | Gallagher Carol Giltner | G-Gift | 42,000 | $50K |
| 2026-06-04 | FLOWERS KIRSTEN | A-Award | 42,000 | $50K |
| 2026-06-04 | BAUM CHARLES M | A-Award | 42,000 | $50K |
| 2026-03-05 | Carulli Michael | A-Award | 240,000 | $367K |
| 2026-03-05 | Ticktin Robert | A-Award | 319,270 | $488K |
| 2026-03-05 | Jalota Deepika | A-Award | 303,310 | $464K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $30.3M | $73.3M | $361.4M | $172.5M | $108.3M | $37.7M | $40.9M | $38.0M |
| Placements à Court Terme | $31.6M | $28.2M | 0 | $124.7M | $132.8M | $165.4M | $128.6M | $75.0M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $62.2M | $102.1M | $364.8M | $301.3M | $247.0M | $207.4M | $175.7M | $115.2M |
| Immobilisations Corporelles | $1.0M | $739000 | $569000 | $13.2M | $20.5M | $19.0M | $1.6M | $1.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $63.5M | $103.0M | $365.5M | $331.6M | $270.3M | $252.2M | $191.3M | $116.6M |
| Dettes Fournisseurs | $1.0M | $2.8M | $1.6M | $3.2M | $3.0M | $3.2M | $6.6M | $3.2M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | $352000 | 0 |
| Passifs Courants | $2.3M | $4.5M | $6.4M | $12.2M | $10.8M | $14.0M | $14.4M | $11.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $435000 |
| Passifs Totaux | $109.6M | $173.5M | $6.4M | $23.0M | $24.3M | $26.5M | $15.2M | $11.8M |
| Réserves | -$50.1M | -$75.4M | -$109.9M | -$167.7M | -$241.0M | -$310.0M | -$368.7M | -$446.5M |
| Capitaux Propres | -$46.1M | -$70.5M | $359.1M | $308.6M | $246.0M | $225.7M | $176.1M | $104.7M |
| Dette Totale | $107.2M | 0 | 0 | $11.2M | $14.0M | $13.3M | $1.2M | $838000 |
| Dette Nette | $45.3M | -$101.5M | -$361.4M | -$286.0M | -$227.1M | -$189.8M | -$168.3M | -$112.1M |
| Fonds de Roulement | $59.9M | $97.6M | $358.4M | $289.1M | $236.2M | $193.4M | $161.3M | $103.8M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 7.70 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -3.41 |
Rentabilité
| Rentabilité des capitaux propres | -78.11% |
| Rentabilité du capital investi | -111.08% |
| Rentabilité des actifs | -91.66% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACRV · ATYR · BMEA · CBUS · IMUX · LITS · RLMD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de PMVP: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions